159 related articles for article (PubMed ID: 21042916)
21. Dorsal pancreatic duct dominance in pancreaticobiliary maljunction.
Kamisawa T; Egawa N; Nakajima H; Matsukawa M
Pancreas; 2005 Apr; 30(3):e60-3. PubMed ID: 15782090
[TBL] [Abstract][Full Text] [Related]
22. Significance of CD44s and CD44v6 expression in pancreaticobiliary maljunction.
Tsuchida A; Nagakawa Y; Kasuya K; Matudo T; Kyo B; Suzuki Y; Aoki T; Sato E; Nagao T; Itoi T
Hepatogastroenterology; 2011; 58(112):1877-81. PubMed ID: 22024057
[TBL] [Abstract][Full Text] [Related]
23. Pancreaticobiliary maljunction: pathophysiological and clinical aspects and the impact on biliary carcinogenesis.
Matsumoto Y; Fujii H; Itakura J; Matsuda M; Yang Y; Nobukawa B; Suda K
Langenbecks Arch Surg; 2003 Apr; 388(2):122-31. PubMed ID: 12684801
[TBL] [Abstract][Full Text] [Related]
24. Elevated bile amylase level without pancreaticobiliary maljunction is a risk factor for gallbladder carcinoma.
Fujimoto T; Ohtsuka T; Nakashima Y; Gotoh Y; Date K; Mori Y; Sadakari Y; Takahata S; Oda Y; Nakamura M
J Hepatobiliary Pancreat Sci; 2017 Feb; 24(2):103-108. PubMed ID: 28002646
[TBL] [Abstract][Full Text] [Related]
25. Pancreaticobiliary maljunction and biliary cancer.
Kamisawa T; Kuruma S; Tabata T; Chiba K; Iwasaki S; Koizumi S; Kurata M; Honda G; Itoi T
J Gastroenterol; 2015 Mar; 50(3):273-9. PubMed ID: 25404143
[TBL] [Abstract][Full Text] [Related]
26. High expression of karyopherin-α2 and stathmin 1 is associated with proliferation potency and transformation in the bile duct and gall bladder epithelia in the cases of pancreaticobiliary maljunction.
Saito F; Araki K; Yokobori T; Ishii N; Tsukagoshi M; Watanabe A; Kubo N; Altan B; Shirabe K; Kuwano H
J Surg Oncol; 2016 Sep; 114(4):462-8. PubMed ID: 27338241
[TBL] [Abstract][Full Text] [Related]
27. Chronic inflammatory changes seen in gallbladders of patients with pancreatico-biliary malunion years after transduodenal sphincterotomy: is it a precursor for gallbladder carcinoma?
Ali AE; Blythe AI; Ford WD
Pediatr Surg Int; 2008 Sep; 24(9):1005-8. PubMed ID: 18668255
[TBL] [Abstract][Full Text] [Related]
28. Prophylactic excision of the gallbladder and bile duct for patients with pancreaticobiliary maljunction.
Kobayashi S; Asano T; Yamasaki M; Kenmochi T; Saigo K; Ochiai T
Arch Surg; 2001 Jul; 136(7):759-63. PubMed ID: 11448385
[TBL] [Abstract][Full Text] [Related]
29. Pancreaticobiliary maljunction.
Kamisawa T; Takuma K; Anjiki H; Egawa N; Kurata M; Honda G; Tsuruta K; Sasaki T
Clin Gastroenterol Hepatol; 2009 Nov; 7(11 Suppl):S84-8. PubMed ID: 19896105
[TBL] [Abstract][Full Text] [Related]
30. Preferable operative age of choledochal dilation types to prevent patients with pancreaticobiliary maljunction from developing biliary tract carcinogenesis.
Kobayashi S; Ohnuma N; Yoshida H; Ohtsuka Y; Terui K; Asano T; Ryu M; Ochiai T
Surgery; 2006 Jan; 139(1):33-8. PubMed ID: 16364715
[TBL] [Abstract][Full Text] [Related]
31. Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union.
Tanno S; Obara T; Fujii T; Mizukami Y; Shudo R; Nishino N; Ura H; Klein-Szanto AJ; Kohgo Y
Cancer; 1998 Jul; 83(2):267-75. PubMed ID: 9669809
[TBL] [Abstract][Full Text] [Related]
32. A new model for pancreaticobiliary maljunction without bile duct dilatation: demonstration of cell proliferation in the gallbladder epithelium.
Kaneko K; Ando H; Umeda T; Murahashi O; Hiraiwa K; Niimi N; Hossain M; Ito T
J Surg Res; 1996 Jan; 60(1):115-21. PubMed ID: 8592401
[TBL] [Abstract][Full Text] [Related]
33. Mucosal changes of the gallbladder in anomalous union with the pancreatico-biliary duct system.
Yamamoto M; Nakajo S; Tahara E; Ito M; Taniyama K; Shimamoto F; Miyoshi N; Hayashi Y; Akiyama H; Nakai S
Pathol Res Pract; 1991 Mar; 187(2-3):241-6. PubMed ID: 2068006
[TBL] [Abstract][Full Text] [Related]
34. The relation between carcinoma of the gallbladder and an anomalous connection between the choledochus and the pancreatic duct.
Nagata E; Sakai K; Kinoshita H; Kobayashi Y
Ann Surg; 1985 Aug; 202(2):182-90. PubMed ID: 4015223
[TBL] [Abstract][Full Text] [Related]
35. The elevated mRNA content as a potential indicator of precancerous states of the gallbladder mucosa in patients with pancreaticobiliary maljunction.
Miura Y; Ichikawa Y; Ishikawa T; Sekido H; Nakano A; Mitsuhashi M; Shimada H
Oncol Rep; 1998; 5(4):845-51. PubMed ID: 9625830
[TBL] [Abstract][Full Text] [Related]
36. Risk factor for extrahepatic bile duct cancer in patients with anomalous pancreaticobiliary ductal union.
Jung YS; Lee KJ; Kim H; Kim WH; Kim IG; Yoo BM; Kim JH; Kim MW
Hepatogastroenterology; 2004; 51(58):946-9. PubMed ID: 15239220
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of bile reflux into the pancreatic duct without pancreaticobiliary maljunction assessed by intraoperative cholangiography.
Ueno K; Ajiki T; Murakami S; Fujita T; Matsumoto T; Shinozaki K; Fukumoto T; Ku Y
Asian J Endosc Surg; 2015 Aug; 8(3):296-302. PubMed ID: 25756368
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical detection of 8-hydroxy-2'-deoxyguanosine in gallbladder epithelium of patients with pancreaticobiliary maljunction.
Otani K; Shimizu S; Chijiiwa K; Yamaguchi K; Noshiro H; Tanaka M
Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1363-9. PubMed ID: 11692064
[TBL] [Abstract][Full Text] [Related]
39. Altered expression levels of occludin, claudin-1 and myosin light chain kinase in the common bile duct of pediatric patients with pancreaticobiliary maljunction.
Huang SG; Guo WL; Zhou ZC; Li JJ; Yang FB; Wang J
BMC Gastroenterol; 2016 Jan; 16():7. PubMed ID: 26772979
[TBL] [Abstract][Full Text] [Related]
40. Precancerous conditions of biliary tract cancer in patients with pancreaticobiliary maljunction: reappraisal of nationwide survey in Japan.
Hasumi A; Matsui H; Sugioka A; Uyama I; Komori Y; Fujita J; Aoki H
J Hepatobiliary Pancreat Surg; 2000; 7(6):551-5. PubMed ID: 11180886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
